Please use a PC Browser to access Register-Tadawul
Get It
FDA Approves Label Update For Gilead's Kite's Yescarta
Gilead Sciences, Inc. GILD | 144.99 | +0.42% |
– Limitations of Use Removed for Rare and Aggressive Form of non-Hodgkin Lymphoma Based on Manageable Safety Profile with No New Safety Signals Identified –
